The genetic test will be available to eye doctors by the end of 2011. Applying gene therapy to humans in a FDA monitored clinical trial is planned.
Genevolve Vision Diagnostics Inc. has developed a non-invasive molecular diagnostic for all major forms of congenital color blindness. It is the firs ...